Aktiesnakken — Februar 2010
-
320 mill både sales og development milestones
-
Det er kun nordamerika og india
-
og first refusal på kina
-
All of the upside for the other territories
-
ja så han er gået igennem den deal.
-
Spectrum er et US based company
-
fokuseret på onc
-
good financial strenght
-
her er den præsentaqtion topo bruger og aka skriver ud fra http://www.topotarget.com/multimedia/TT_Presentation_-_Spectrum_January_2011.pdf
-
134 mill i cash og ingen gæld
-
stigende revenue and good sales growth
-
ranked no. 22 fastest growing company
-
highly experienced oncology teams
-
så vi forstår at vi skal være glade for at være i klub med dem
-
her er den præsentation topo bruger og aka skriver ud fra http://www.topotarget.com/multimedia/TT_Presentation_-_Spectrum_January_2011.pdf
-
Belinostat vil være en top prioritet for begge firmaer
-
nu ser vi åbenbart et billede af CEO´en
-
Nu kommer Peter Buhl
-
de har åbenbart et stof i nhl, med cd20!
-
du skal snart til at finde salgsknappen aka, hvis du sagde 4,3
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind